Terns Pharmaceuticals (TERN) is getting attention after announcing that early-stage trial results for its CML drug candidate, TERN-701, were selected for oral presentation at this year's American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback